Effects of exogenous surfactant instillation in clinical lung transplantation: A prospective, randomized trial

Journal of Thoracic and Cardiovascular Surgery

Volumn 133, Issue 6, 2007, Pages 1620-1625

  Strüber, Martin ^a   Fischer, Stefan ^a   Niedermeyer, Jost ^a   Warnecke, Gregor ^a   Gohrbandt, Bernhard ^a   Görler, Adelheid ^a   Simon, Andre R ^a   Haverich, Axel ^a   Hohlfeld, Jens M ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; METHYLPREDNISOLONE; MYCOPHENOLIC ACID; PREDNISONE; SURFACTANT;

ADULT; ARTICLE; BRONCHOSCOPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FORCED EXPIRATORY VOLUME; GRAFT REJECTION; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN TISSUE; LUNG FUNCTION TEST; LUNG LAVAGE; LUNG TRANSPLANTATION; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL;

ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; BRONCHOALVEOLAR LAVAGE FLUID; FEMALE; GRAFT REJECTION; HUMANS; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PULMONARY SURFACTANTS; RESPIRATORY FUNCTION TESTS; TISSUE DONORS; TREATMENT OUTCOME;

EID: 34249017748     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2006.12.057     Document Type: Article

References (21)

1. Warnecke G., Struber M., Fraud S., Hohlfeld J.M., and Haverich A. Combined exogenous surfactant and inhaled nitric oxide therapy for lung ischemia-reperfusion injury in minipigs. Transplantation 71 (2001) 1238-1244
2. Struber M., Wilhelmi M., Harringer W., Niedermeyer J., Anssar M., Kunsebeck A., et al. Flush perfusion with low potassium dextran solution improves early graft function in clinical lung transplantation. Eur J Cardiothorac Surg 19 (2001) 190-194
3. Fischer S., Matte-Martyn A.J., De Perrot M., Waddell T.K., Sekine Y., Hutcheon M., et al. Low-potassium dextran preservation solution improves lung function after human lung transplantation. J Thorac Cardiovasc Surg 121 (2001) 594-596
4. Struber M. What is the role of surfactant and inhaled nitric oxide in lung transplantation?. Crit Care 6 (2002) 186-187 Epub 2002 May 9
5. Fischer S., Struber M., Simon A.R., Anssar M., Wilhelmi M., Leyh R.G., et al. Video-assisted minimally invasive approach in clinical bilateral lung transplantation. J Thorac Cardiovasc Surg 122 (2001) 1196-1198
6. Enhorning G. Pulsating bubble technique for evaluating pulmonary surfactant. J Appl Physiol 43 (1977) 198-203
7. Hohlfeld J.M., Ahlf K., Enhorning G., Balke K., Erpenbeck V.J., Petschallies J., et al. Dysfunction of pulmonary surfactant in asthmatics after segmental allergen challenge. Am J Respir Crit Care Med 159 (1999) 1803-1809
8. Novick R.J., Gilpin A.A., Gehman K.E., Ali I.S., Veldhuizen R.A., Duplan J., et al. Mitigation of injury in canine lung grafts by exogenous surfactant therapy. J Thorac Cardiovasc Surg 113 (1997) 342-353
9. Maccherini M., Keshavjee S.H., Slutsky A.S., Patterson G.A., and Edelson J.D. The effect of low-potassium-dextran versus Euro-Collins solution for preservation of isolated type II pneumocytes. Transplantation 52 (1991) 621-626
10. Veldhuizen R.A., Lee J., Sandler D., Hull W., Whitsett J.A., Lewis J., et al. Alterations in pulmonary surfactant composition and activity after experimental lung transplantation. Am Rev Respir Dis 148 (1993) 208-215
11. Seeger W., Stohr G., Wolf H.R., and Neuhof H. Alteration of surfactant function due to protein leakage: special interaction with fibrin monomer. J Appl Physiol 58 (1985) 326-338
12. Novick R.J., MacDonald J., Veldhuizen R.A., Wan F., Duplan J., Denning L., et al. Evaluation of surfactant treatment strategies after prolonged graft storage in lung transplantation. Am J Respir Crit Care Med 154 (1996) 98-104
13. Veldhuizen R.A., Marcou J., Yao L.J., McCaig L., Ito Y., and Lewis J.F. Alveolar surfactant aggregate conversion in ventilated normal and injured rabbits. Am J Physiol 270 1 Pt 1 (1996) L152-L158
14. Struber M., Hohlfeld J.M., Fraund S., Kim P., Warnecke G., and Haverich A. Low-potassium dextran solution ameliorates reperfusion injury of the lung and protects surfactant function. J Thorac Cardiovasc Surg 120 (2000) 566-572
15. Hohlfeld J.M., Tiryaki E., Hamm H., Hoymann H.G., Krug N., Haverich A., et al. Pulmonary surfactant activity is impaired in lung transplant recipients. Am J Respir Crit Care Med 158 (1998) 706-712
16. Meyers B.F., de la Morena M., Sweet S.C., Trulock E.P., Guthrie T.J., Mendeloff E.N., et al. Primary graft dysfunction and other selected complications of lung transplantation: a single-center experience of 983 patients. J Thorac Cardiovasc Surg 129 (2005) 1421-1429
17. Gohrbandt B., Sommer S.P., Fischer S., Hohlfeld J.M., Warnecke G., Haverich A., et al. Iloprost to improve surfactant function in porcine pulmonary grafts stored for twenty-four hours in low-potassium dextran solution. J Thorac Cardiovasc Surg 129 (2005) 80-86
18. Sommer S.P., Gohrbandt B., Fischer S., Hohlfeld J.M., Warnecke G., Avsar M., et al. Glutathione improves the function of porcine pulmonary grafts stored for twenty-four hours in low-potassium dextran solution. J Thorac Cardiovasc Surg 130 (2005) 864-869
19. Gohrbandt B., Fischer S., Warnecke G., Avsar M., Sommer S.P., Haverich A., et al. Glycine intravenous donor preconditioning is superior to glycine supplementation to low-potassium dextran flush preservation and improves graft function in a large animal lung transplantation model after 24 hours of cold ischemia. J Thorac Cardiovasc Surg 131 (2006) 724-729
20. Struber M., Hohlfeld J.M., Kofidis T., Warnecke G., Niedermeyer J., Sommer S.P., et al. Surfactant function in lung transplantation after 24 hours of ischemia: advantage of retrograde flush perfusion for preservation. J Thorac Cardiovasc Surg 123 (2002) 98-103 Comment in: J Thorac Cardiovasc Surg. 2002;123:3-5
21. Gregory T.J., Steinberg K.P., Spragg R., Gadek J.E., Hyers T.M., Longmore W.J., et al. Bovine surfactant therapy for patients with acute respiratory distress syndrome. Am J Respir Crit Care Med 155 (1997) 1309-1315